Deep-pocketed investors have adopted a bearish approach towards Amgen (NASDAQ:AMGN), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Amgen wasn’t one of them. The 10 stocks that made the cut ...

with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Amgen is currently a Zacks Rank ...

Our analysis of options history for Amgen (NASDAQ:AMGN) revealed 19 unusual trades. Delving into the details, we found 26% of traders were bullish, while 63% showed bearish tendencies. Out of all ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Deep-pocketed investors have adopted a bullish approach towards Amgen (NASDAQ:AMGN), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled ...

Amgen's sales growth is safe and should improve ... Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this. On rare occasions, our expert team ...

with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Amgen is currently a Zacks Rank #3 (Hold).

Before you buy stock in Amgen, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Amgen wasn’t one ...

Looking at options history for Amgen (NASDAQ:AMGN) we detected 14 trades. If we consider the specifics of each trade, it is accurate to state that 64% of the investors opened trades with bullish ...

Stock Advisor returns as of April 1, 2025 David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amgen, Baidu, and PayPal. The Motley Fool ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.